Status:
COMPLETED
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Lead Sponsor:
International Vaccine Institute
Collaborating Sponsors:
Centers for Disease Control and Prevention
Hechi City Center for Disease Centrol
Conditions:
Typhoid
Paratyphoid Fever
Eligibility:
All Genders
5-60 years
Phase:
PHASE4
Brief Summary
This study is part of International Vaccine Institute (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The purpos...
Detailed Description
Typhoid fever is a major cause of morbidity worldwide. The disease predominantly affects school-aged children, is more prevalent in urban areas, may last for several weeks and can lead to serious comp...
Eligibility Criteria
Inclusion
- Registered in the project census
Exclusion
- Pregnant
- Lactating
- Fever \> 37.5 degrees Celsius, axillary
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
96468 Patients enrolled
Trial Details
Trial ID
NCT00131833
Start Date
October 1 2001
End Date
November 1 2006
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hechi City Center for Disease Control
Hechi, Guangxi, China, 54700